1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025

  • January 2017
  • 62 pages
  • GlobalData
Report ID: 2522995

Summary

Table of Contents

Search Inside

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025

Summary

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body (CDC, 2015; Mayo Clinic, 2016). In RA, the body’s immune system attacks the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory response (CDC, 2015). The disease can lead to premature mortality, disability, and decreased quality of life.

In the 8MM, epidemiologists forecast that the diagnosed incident cases of RA will increase from 195,592 cases in 2015 to 216,467 cases in 2025, at an Annual Growth Rate (AGR) of 1.07%. The US will have the highest number of diagnosed incident cases of RA among the 8MM throughout the forecast period, while Spain will have the lowest.
Epidemiologists forecast that the diagnosed prevalent cases of RA will increase from 4,354,194 cases in 2015 to 4,931,572 cases in 2025, at an AGR of 1.33%. The US will have the highest number of diagnosed prevalent cases of RA among the 8MM throughout the forecast period, while Australia will have the lowest.

The report “EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends of RA in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases, and total prevalent cases of RA segmented by age and sex in these eight markets. The diagnosed prevalent cases of RA are further segmented by severity in the 8 MM for the forecast period.

Scope

- The Rheumatoid Arthritis (RA) EpiCast Report provides an overview of the risk factors and global trends of RA in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases, and total prevalent cases of RA segmented by age and sex in these eight markets. The diagnosed prevalent cases of RA are further segmented by severity in the 8 MM for the forecast period.
- The RA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The RA EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global RA market.
- Quantify patient populations in the global RA market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for RA therapeutics in each of the markets covered.
- Identify the percentage of diagnosed prevalent cases of RA by severity.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Juvenile Rheumatoid Arthritis - Pipeline Insight, 2017

  • $ 1250
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s, “Juvenile Rheumatoid Arthritis-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Juvenile Rheumatoid Arthritis. ...

Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2017

  • $ 2500
  • Industry report
  • August 2017
  • by GlobalData

Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2017" provides ...

Europe Market Report for Minimally Invasive Sacroiliac Joint Fusion 2017 - MedCore

  • $ 3995
  • Industry report
  • July 2017
  • by iData Research, Inc.

Studies have shown that over 80% of the population will suffer from lower back pain at some point in their lives. A majority of these cases can be attributed to two main causes: general factors, such as ...


Download Unlimited Documents from Trusted Public Sources

Vaccine Market and Influenza Statistics in India

  • August 2017
    6 pages
  • Vaccine  

    Influenza  

    Diabetes  

  • India  

    United States  

View report >

Smoking Statistics Industry in the UK and Europe

  • August 2017
    156 pages
  • Smoking Statist...  

    Mortality  

    Sexually Transm...  

  • Europe  

    United Kingdom  

View report >

Pathology Statistics - Forecast

  • August 2017
    4 pages
  • Chronic Disease  

    Diabetes  

View report >

Related Market Segments :

Arthritis

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.